Serina Therapeutics Begins First-in-Patient Dosing in Phase 1b Trial of SER‑252 for Advanced Parkinson’s Disease

As reported on RTT News, Serina Therapeutics has initiated patient dosing in its Phase 1b registrational study of SER‑252, marking a significant milestone for the company’s lead investigational therapy for…

Continue Reading Serina Therapeutics Begins First-in-Patient Dosing in Phase 1b Trial of SER‑252 for Advanced Parkinson’s Disease

Investigational Cell Therapy Bemdaneprocel Shows Sustained Safety and Promising Motor Improvements at 36 Months in Parkinson’s Disease Trial

Bayer AG and its subsidiary BlueRock Therapeutics LP have announced encouraging 36-month follow-up data from the Phase I exPDite clinical trial of bemdaneprocel (BRT-DA01), an investigational cell therapy aimed at…

Continue Reading Investigational Cell Therapy Bemdaneprocel Shows Sustained Safety and Promising Motor Improvements at 36 Months in Parkinson’s Disease Trial

Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia

A new study published in Aging-US reveals that Parkinson’s disease (PD) patients diagnosed in their 80s are significantly more likely to exhibit amyloid-beta buildup, which is an early marker of…

Continue Reading Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia
“I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic
source: pixabay.com

“I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic

It started with fatigue. Then came problems with moving, hand tremors and problems walking. Multiple sclerosis was ruled out by magnetic resonance imaging (MRI). But the trouble didn’t go away.…

Continue Reading “I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic
There’s $12.7 Million Behind This New Parkinson’s Hypothesis
Source: https://pixabay.com/en/anatomical-anatomy-body-gut-health-2261006/

There’s $12.7 Million Behind This New Parkinson’s Hypothesis

A new biotech company in Philadelphia called Enterin announced recently that their company has raised a whopping $12.7 million to support the hypothesis that Parkinson's disease starts in the gut,…

Continue Reading There’s $12.7 Million Behind This New Parkinson’s Hypothesis
Breaking News in Parkinson’s Disease Research
Source: https://pixabay.com/en/connection-fractal-neural-pathways-647206/

Breaking News in Parkinson’s Disease Research

There's some new information available about Parkinson's disease, and researchers are really excited about it. Earlier this month, researchers found that visual system changes in recently diagnosed Parkinson's patients can…

Continue Reading Breaking News in Parkinson’s Disease Research